Expert Opinion on Pharmacotherapy, 21(11), 13191328
Were here to help you achieve your best health
What matters most is: The receptor pathways activated (single, dual, or triple agonism) The degree of weight loss achieved at clinical endpoints The tolerability profile at each dose escalation By these measures, Retatrutides dosing strategy has set a new benchmark for weight-loss drugs currently under development
( Another study investigated the influence and underlying mechanism of exendin-4, a glucagon-like peptide 1 receptor agonist, on inflammation in both liver and vessel walls simultaneously
Powell-Wiley TM, Poirier P, Burke LE, et al
Common side effects were predominantly gastrointestinal, including nausea, diarrhea, constipation, and vomiting, primarily during dose escalation [45] [46]